Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Outcomes with luspatercept in patients with β-thalassemia: A systematic review and meta-analysis

Hafsa Shahid, Nihal Babiker, Wania Ur Rehamn, Syed Mohamin Abbas Shah, Faris Babker, Menna Sarhan, Hind El Azzazi, Hafiz Muhammad Hannan Javed, Arfa Ahmad, Muhammad Yasir

Blood (2025) 146 (Supplement 1): 7961.

https://doi.org/10.1182/blood-2025-7961

Published: 2025

Journal Articles

Eculizumab for hyperhemolysis syndrome in sickle cell disease: A systematic review and meta-analysis

Moazzam Shahzad, Muhammad Shaheer Mannan, Hafiz Muhammad Hannan Javed, Farooq Ashraf, Fatima Sial, Syed Maaz Tariq, Salman Khan

Blood (2025) 146 (Supplement 1): 6501.

https://doi.org/10.1182/blood-2025-6501

Published: 2025

Journal Articles

Evaluating efficacy and safety of hydroxyurea and thalidomide for beta-thalassemia: A systematic review andmeta-analysis.

Maheen Imran Shaikh, Mehak Gul, Syed Maaz, Inza Saif, Amna Mazhar, Sarah Imran, FNU Kalpina, Hafsa Shahid, Muhammad Yasir, Arfa Ahmad, Hafiz Muhammad Hannan Javed

Blood (2025) 146 (Supplement 1): 6473.

https://doi.org/10.1182/blood-2025-6473

Published: 2025

Journal Articles

Combination of brentuximab vedotin and nivolumab in the management of Hodgkin lymphoma: A systematic review and meta-analysis

Hafsa Shahid, Vikash Kumar Karmani, Hafiz Muhammad Hannan Javed, Arfa Ahmad, Muhammad Yasir

Blood (2025) 146 (Supplement 1): 7147.

https://doi.org/10.1182/blood-2025-7147

Published: 2025

Journal Articles

CAR-T cell therapy in multiple myeloma in a front-line setting: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Hafsa Shahid, Farooq Ashraf, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7605.

https://doi.org/10.1182/blood-2025-7605

Published: 2025

Journal Articles

Efficacy of tocilizumab prophylaxis in preventing cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: A systematic review and meta-analysis

Moazzam Shahzad, Hafiz Muhammad Hannan Javed, Hafsa Shahid, Anas Zayad, Rohan Parvathala, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Al-Ola Abdallah

Blood (2025) 146 (Supplement 1): 7602.

https://doi.org/10.1182/blood-2025-7602

Published: 2025

Journal Articles

Epidemiological trends in leukemia and heart failure-associated mortality: A CDC wonder database analysis

Hafsa Shahid, Ahmad Qaisar, Prachi Dawer, Muhammad Ans, Hafiz Muhammad Hannan Javed, Arfa Ahmad, Muhammad Yasir

Blood (2025) 146 (Supplement 1): 2824.

https://doi.org/10.1182/blood-2025-2824

Published: 2025

Journal Articles

The role of high-dose vitamin c in management of hematological malignancies: Asystematic review and meta-analysis

Zeeshan Sattar, Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Amir Kasaeian, Iman Menbary, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 8116.

https://doi.org/10.1182/blood-2025-8116

Published: 2025

Journal Articles

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Hafsa Shahid, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6875.

https://doi.org/10.1182/blood-2025-6875

Published: 2025

Journal Articles

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Zeeshan Sattar, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Fatima Sial, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6873.

https://doi.org/10.1182/blood-2025-6873

Published: 2025

Journal Articles

Outcomes with repeat CAR-t cell therapy: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Fatima Sial, Farooq Ashraf, Aman Ullah, Muhammad Umair Mushtaq, Moazzam Shahzad, Salman Khan

Blood (2025) 146 (Supplement 1): 7632.

https://doi.org/10.1182/blood-2025-7632

Published: 2025

Journal Articles

Outcomes with a fixed duration combination of bruton tyrosine kinase inhibitors and venetoclax in chronic lymphocytic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Farooq Ashraf, Fatima Sial, Hafsa Shahid, Syed Muhammad Ali Najafi, Atif Butt, Muhammad Shaheer Mannan, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2025-7432

Published: 2025

Journal Articles

Preemptive Rituximab in patients with ADAMTS13 relapse in thrombotic thrombocytopenic purpura: A systematic review

Farooq Ashraf, Hafiz Muhammad Hannan Javed, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Michael Jaglal, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 1333.

https://doi.org/10.1182/blood-2025-1333

Published: 2025

Journal Articles

Outcomes with a combination of treosulfan and fludarabine in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Hafsa Shahid, Mudassar Nisar, Fatima Hussain, Fatima Sial, Barika Fatima, Sajjal Zia, Annalisa Palazzi, Arfa Ahmad, Muhammad Yasir, Hafiz Muhammad Hannan Javed

Blood (2025) 146 (Supplement 1): 4604.

https://doi.org/10.1182/blood-2025-4604

Published: 2025

Journal Articles

Mortality trends of sepsis in patients with leukemia in the United States (1999–2020): A CDC wonder database analysis

Hafsa Shahid, Anisha Manzoor, Sania Batool, Prachi Dawer, Hafiz Muhammad Hannan Javed, Arfa Ahmad, Muhammad Yasir

Blood (2025) 146 (Supplement 1): 4603.

https://doi.org/10.1182/blood-2025-4603

Published: 2025

Journal Articles

Outcomes with prophylactic anticoagulation in hemolytic anemias: A systematic review

Hafiz Muhammad Hannan Javed, Aminah Tayyab, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6665.

https://doi.org/10.1182/blood-2025-6665

Published: 2025

Journal Articles

Trends and disparities in mortality from chronic lymphocytic leukemia in the geriatric population in the United States from 1999 to 2020: A nationwide analysis

Muhammad Shaheer Mannan, Allahdad Khan, Arfa Ahmad, Ayesha Fatima, Hafiz Muhammad Hannan Javed, Huzaifa Noor, Anisha Manzoor, Muhammad Talha, Muhammad Asim Agha, Saad Aslam, Muhammad Hussnain Sadiq, Muhammad Hassan Cheema, Tahreem Naz, Abdul basit Khan, FNU Muhibullah, Ahmad Basharat, Muhammad Yasir

Blood (2025) 146 (Supplement 1): 8016.

https://doi.org/10.1182/blood-2025-8016

Published: 2025

Journal Articles

Outcomes with itacitinib prophylaxis for cytokine release syndrome: A systematic review

Hafiz Muhammad Hannan Javed, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7691.

https://doi.org/10.1182/blood-2025-7691

Published: 2025

Journal Articles

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Zeeshan Sattar, Hafsa Shahid, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6869.

https://doi.org/10.1182/blood-2025-6869

Published: 2025

Journal Articles

Temporal trends and disparities in non-Hodgkin lymphoma related mortality along the US-Mexico border from 1999 to 2020: CDC wonder analysis

Muhammad Shaheer Mannan, Allahdad Khan, Arfa Ahmad, Saniya Ishtiaq, Kumail Ali, Nimra Shafi, Muhammad Raffey Shabbir, Nouman Shafique, Abdul basit Khan, Raheel Ahmed, Ahmad Basharat, Muhammad Yasir, Hafiz Muhammad Hannan Javed

Blood (2025) 146 (Supplement 1): 8072.

https://doi.org/10.1182/blood-2025-8072

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Outcomes with luspatercept in patients with β-thalassemia: A systematic review and meta-analysis

Eculizumab for hyperhemolysis syndrome in sickle cell disease: A systematic review and meta-analysis

Evaluating efficacy and safety of hydroxyurea and thalidomide for beta-thalassemia: A systematic review andmeta-analysis.

Combination of brentuximab vedotin and nivolumab in the management of Hodgkin lymphoma: A systematic review and meta-analysis

CAR-T cell therapy in multiple myeloma in a front-line setting: A systematic review and meta-analysis

Efficacy of tocilizumab prophylaxis in preventing cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: A systematic review and meta-analysis

Epidemiological trends in leukemia and heart failure-associated mortality: A CDC wonder database analysis

The role of high-dose vitamin c in management of hematological malignancies: Asystematic review and meta-analysis

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes with repeat CAR-t cell therapy: A systematic review and meta-analysis

Outcomes with a fixed duration combination of bruton tyrosine kinase inhibitors and venetoclax in chronic lymphocytic leukemia: A systematic review and meta-analysis

Preemptive Rituximab in patients with ADAMTS13 relapse in thrombotic thrombocytopenic purpura: A systematic review

Outcomes with a combination of treosulfan and fludarabine in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Mortality trends of sepsis in patients with leukemia in the United States (1999–2020): A CDC wonder database analysis

Outcomes with prophylactic anticoagulation in hemolytic anemias: A systematic review

Trends and disparities in mortality from chronic lymphocytic leukemia in the geriatric population in the United States from 1999 to 2020: A nationwide analysis

Outcomes with itacitinib prophylaxis for cytokine release syndrome: A systematic review

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Temporal trends and disparities in non-Hodgkin lymphoma related mortality along the US-Mexico border from 1999 to 2020: CDC wonder analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only